Medivis, founded in New York City, is a medical technology company dedicated to revolutionizing medical imaging and surgical navigation through the use of augmented reality (AR) and artificial intelligence (AI). Their core mission is to improve surgical outcomes and drive cost efficiencies for medical institutions. Medivis offers products such as SurgicalAR, an FDA-cleared technology that transforms complex 2D imaging like MRI and CT scans into real-time 3D visualizations superimposed onto the patient's body.
Notable figures affiliated with Medivis include leading surgeons and technologists who contribute to the company's innovative approach. The company has garnered significant investment from prominent venture capital firms and has achieved key milestones, including FDA clearance for their SurgicalAR technology. Medivis has made a substantial impact by enhancing the precision of surgical procedures and reducing operational costs for healthcare providers.
